<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-30T00:06:20Z</responseDate><request verb="GetRecord" identifier="oai:munzur-rdlopen.rawdatalibrary.net:munzur/3196" metadataPrefix="oai_dc">https://munzur-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:munzur-rdlopen.rawdatalibrary.net:munzur/3196</identifier><datestamp>2026-10-28T15:39:28Z</datestamp><setSpec>openaire</setSpec><setSpec>com_munzur_1</setSpec><setSpec>col_munzur_2</setSpec><setSpec>com_munzur_11</setSpec><setSpec>col_munzur_164</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats</dc:title><dc:creator>Sahin, Kazim</dc:creator><dc:creator>Orhan, Cemal</dc:creator><dc:creator>Kucuk, Osman</dc:creator><dc:creator>Erten, Fusun</dc:creator><dc:creator>Tuzcu, Mehmet</dc:creator><dc:creator>Sahin, Nurhan</dc:creator><dc:creator>Ojalvo, Sara Perez</dc:creator><dc:creator>Komorowski, James Richard</dc:creator><dc:subject>D-biotin</dc:subject><dc:subject>Glucose</dc:subject><dc:subject>Insulin</dc:subject><dc:subject>Lipid parameters</dc:subject><dc:subject>Magnesium biotinate</dc:subject><dc:description>The objective of this study was to investigate the effects of a novel form of biotin (magnesium biotinate) on serum glucose, lipid profile, and hepatic lipid metabolism-related protein levels in rats. Forty-two rats were divided into six groups and fed a standard diet-based egg white powdered diet supplemented with either d-biotin at 0.01, 1, or 100 mg/kg BW or magnesium biotinate at 0.01, 1, or 100 mg/kg BW for 35 days. Neither form of biotin influenced (p &gt; 0.05) serum glucose or insulin concentrations. Serum total cholesterol and triglyceride decreased with biotin from both sources (p &lt; 0.05). Concentrations were lower with magnesium biotinate when comparing the 1 mg/kg dose (p &lt; 0.05). Serum, liver, and brain biotin and liver cyclic guanosine monophosphate (cGMP) concentrations were greater when rats were treated with magnesium biotinate versus d-biotin, particularly when comparing the 1 and 100 mg/kg dose groups (p &lt; 0.05). Both biotin forms decreased the liver SREBP-1c and FAS and increased AMPK-a1, ACC-1, ACC-2, PCC, and MCC levels (p &lt; 0.05). The magnitudes of responses were more emphasized with magnesium biotinate. Magnesium biotinate, compared with a commercial d-biotin, is more effective in reducing serum lipid concentrations and regulating protein levels of lipid metabolism-related biomarkers.</dc:description><dc:publisher>John Libbey</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/munzur/3196</dc:identifier><dc:identifier>https://doi.org/10.1684/mrh.2021.0480</dc:identifier><dc:identifier>0953-1424</dc:identifier><dc:language>en</dc:language><dc:relation>Magnesium Research</dc:relation><dc:rights>info:eu-repo/semantics/closedAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://munzur-rdlopen.rawdatalibrary.net/tr/items/munzur/3196</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>